Startup launched at NCSU lands $2M grant for drugs to regulate bleeding, clotting

Raleigh-based Helixomer, a pre-clinical, drug-development company created at North Carolina State University, has won a $2 million federal grant to advance a pair of novel drugs to regulate bleeding and clotting in patients.

Read More